EU agency issues guideline on biosimilar MS drugs
by on Jan.20, 2012, under Health and Fitness
LONDON (Reuters) – European regulators took another step towards opening the market for copies of biotech drugs on Friday by releasing a draft guideline on how companies should test biosimilar medicines containing interferon beta, used to treat mu…
View full post on Yahoo! Health News
